Completed projects

International grants:

PGP Project CELGENE (2009-2014)
Principal Investigator: Albert Breier (Contract with the Celgene company).
P-glycoprotein Mediated Multidrug Resistance in Radiation-Associated Hematological Malignancies Following the Chernobil Accident (2007-2008)
Principal Investigator: Albert Breier

Slovak Research and Development Agency (APVV):

Preparation of nanostructured interfaces, their integration with bioelements and subsequent use (2012-2015)
Principal Investigator (Institute of Chemistry, SAS): Ján Tkáč
Principal Investigator at IMPG SAS: Zdena Sulová
Antitumour effect of biologically active ligands of nuclear retinoid X receptor heterodimers in tissue carcinoma cell lines (2012-2015)
Principal Investigator (Institute of experimental Endocrinology, SAS): Július Brtko
Principal Investigator at IMPG SAS: Zdena Sulová
PGP APVV-0290-10
Alteration in cell metabolism asocciated with drug transporter P-glycoprotein overexpression in leukemia cells (2011-2014)
Principal Investigator: Zdena Sulová
Overexpression of P-glycoprotein and associated changes in spectrum and levels oligo- and polysaccharides (2008-2010)
Principal Investigator: Zdena Sulová

Grant Agency for Science (VEGA):

PGP VEGA 2/0182/13
Multidrug resistance of leukemia cells on different drugs (2013-2016)
Principal investigator: Zdena Sulová
PGP VEGA 2/0100/12
Overexpression of P-glycoprotein-induced cell changes in leukemia cells (2012-2014)
Principal Investigator: Albert Breier
PGP VEGA 2/0123/10
The effect of P-glycoprotein  and development of multidrug resistance on some aspects of metabolism (2010-2012)
Principal Investigator: Zdena Sulová
PGP VEGA 2/0155/09
Changes of leukemia cells associated with P-glycoprotein mediated multidrug resistance development (2009-2011)
Principal Investigator: Albert Breier